Cargando…
Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges
Metabolic cardiovascular diseases have become a global health concern, and some of their risk factors are linked to several metabolic disorders. They are the leading causes of death in developing countries. Adipose tissues secrete a variety of adipokines that participate in regulating metabolism and...
Autores principales: | Lei, Xiaotian, Qiu, Sheng, Yang, Gangyi, Wu, Qinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311114/ https://www.ncbi.nlm.nih.gov/pubmed/37397515 http://dx.doi.org/10.1016/j.gendis.2022.10.018 |
Ejemplares similares
-
Role of adiponectin in metabolic and cardiovascular disease
por: Lee, Sewon, et al.
Publicado: (2014) -
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
por: Yang, Pingping, et al.
Publicado: (2023) -
Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders
por: Han, Wen, et al.
Publicado: (2022) -
Gut microbiota and cardiovascular disease: opportunities and challenges
por: Kazemian, Negin, et al.
Publicado: (2020) -
Adiponectin Provides Cardiovascular Protection in Metabolic Syndrome
por: Okamoto, Yoshihisa
Publicado: (2011)